Rorze (6323) Q2 2025 earnings summary

Executive summary

• Revenue for the six months ended August 31, 2024, rose 46.9% year-over-year to ¥60,229 million, with operating profit up 72.3% to ¥17,146 million and net profit attributable to shareholders up 61.2% to ¥15,850 million.

• Achieved significant revenue and profit growth driven by strong sales of semiconductor and FPD-related equipment, favorable currency effects, and rebounding demand from AI-related advanced semiconductor needs and increased Chinese manufacturing investment.

• Expanded global operations, including a new subsidiary in the US and a major factory expansion in Vietnam.

Financial highlights

• Gross profit for the period was ¥23,743 million, up from ¥14,868 million year-over-year.

• Operating margin improved significantly, with operating profit at ¥17,146 million (28.5% of sales).

• Comprehensive income reached ¥23,131 million, up 66.6% year-over-year.

• EPS for the period was ¥89.97 (post-split basis).

• FPD-related equipment sales nearly doubled, and life science equipment sales more than doubled year-over-year.

Outlook and guidance

• Maintains full-year guidance, expecting continued robust sales in semiconductor equipment to China, the US, and Taiwan, with full-year revenue forecast at ¥120,784 million, operating profit at ¥31,617 million, and net profit at ¥22,916 million.

• No change to previously announced guidance despite increased SG&A from Nanoverse Technologies acquisition.

• Exchange rates expected to remain stable in the second half; no change to full-year consolidated forecast.